165P Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response (pCR) in HER2-positive early breast cancer (EBC): A sub analysis of PHERGain trial
Gion Cortes, M., Garcia Mosquera, J.J., Pérez-García, J.M., Peg Cámara, V., Guerrero, J.A., López-Montero, L., Mancino, M., Rodríguez Morató, J., Antonarelli, G., Fernández-Murga, L., Serrano García, L., Puglia, V., Llombart Cussac, A., Cortés, J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
27P Impact of chemotherapy (CT) use and stromal tumor-infiltrating lymphocytes (sTILs) in stage I triple-negative breast cancer (TNBC)
Barberi, V., Panet, F., Joval, L., Jaramillo, J.F. Chabla, Adelantado, E. Zamora, Pimentel, I., Puy, M. Borrell, Ezquerra, M. Bellet, Arumi de Dios, M.A., Gomez, L. Sanz, Calzado, E. Monescillo, Ortiz, C., Rezqallah Aron, M.A., Escrivá-De-Romaní, S., Lapena, M. Cruellas, Jimenez, J., Espinosa-Bravo, M., Cámara, V. Peg, Manich, C. Saura, Oliveira, M.
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
29P Long-term performance of residual cancer burden (RCB): Clinical pathological stage (CPS) and CPS+ER+Grade (CPS-EG) models in ER+HER2- breast cancer (BC) patients (pts) after neoadjuvant chemotherapy (NAC) - Role of Ki67 drop and extended endocrine therapy (EET)
Gomez, L. Sanz, Adelantado, E. Zamora, Joval, L., Monescillo, E., Ortiz, C., Trabulo, C.F.P., Garcia, B. Rojas, Pascual, J., Puerto, D.A. Gomez, Salazar, S.A. Bueno, Rivero, J., Gómez, I. Miranda, Ariza, L. Rodriguez, Pardo, P. Gomez, Espinosa-Bravo, M., Manich, C. Saura, Javierre, G. Villacampa, Cámara, V. Peg, Dienstmann, R., Ezquerra, M. Bellet
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
115P Longterm prognostic utility of 70-gene signature by clinical and genomic risks, including Ultralow (gUL) risk patients (pts)
Gomez, L. Sanz, Zamora, E., Joval, L., Velez, C. Ortiz, Puy, M. Borrell, Arumi de Dios, M.A., Puerto, D.A. Gomez, Garces, V. Navarro, Rezqallah Aron, M.A., Cano, K.S. Vega, Escrivá-De-Romaní, S., Mirallas, O., Pimentel, I., Lapena, M. Cruellas, Villacampa, G., Oliveira, M., Manich, C. Saura, Pardo, P. Gomez, Cámara, V. Peg, Bellet-Ezquerra, M.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
63P Ki67 values and MammaPrint (MP) genomic risk in early breast cancer: Correlation by ductal vs lobular histology
Zamora, E., Gomez, L. Sanz, Joval, L., Ortiz Velez, C., Arumi de Dios, M.A., Puy, M. Borrell, Puerto, D.A. Gomez, Leao, I.I.L., Rezqallah Aron, M.A., Garces, V. Navarro, Villacampa, G., Manich, C. Saura, Pardo, P. Gomez, Cámara, V. Peg, Bellet-Ezquerra, M.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
62P KI67 in ER+HER2-negative pure invasive lobular breast carcinoma (ILC). What’s the best Ki67 threshold to differentiate prognosis?
Bellet-Ezquerra, M., Pardo, P. Gomez, Fasani, R., Villacampa, G., Portu, M., Serna, G., Joval, L., Petit, A., Ortega, A. Fernandez, Jimenez, J., Zamora, E., Gil, M.J., Gomez, L. Sanz, Viaplana, C., Gallego, F., Cámara, V. Peg, Manich, C. Saura, Simon, S. Pernas, Nuciforo, P.G.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article